CLE-030
CLE-030 is a KCNQ2 agonist with non-gating-dependent current-modulating activity. CLE-030 modulates neuronal network activity. CLE-030 can be used in studies related to pain, epilepsy and benign familial neonatal convulsions.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2803111-66-0
- Fòrmula: C20H20Br2N4OS2
- Peso molecular:556.34
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
CLE-030 (Compound 34) (10 μM; for at least 3 min) increases channel currents in CHO-K1 cells transfected with human KCNQ2[1].
CLE-030 (0.1-10 μM) potently activates wild-type human KCNQ2 channels expressed in CHO cells, with an EC50 of 3.9 μM. It enhances channel currents without altering voltage sensitivity or gating kinetics[2].
CLE-030 (0.1-10 μM) shows significantly reduced activation potency toward W236A, L299A, and V302A mutant KCNQ2 channels expressed in CHO cells[2].
CLE-030 (0.1-10 μM) selectively activates human KCNQ2, KCNQ4 and KCNQ5 channels expressed in CHO cells, and exhibits no significant activity against KCNQ1, KCNQ3A315T, BKCa, Kv1.2, Kir4.1 or TREK-1 channels[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 2803111-66-0
-
Peso molecular 556.34
-
Fòrmula C20H20Br2N4OS2
-
SMILES
O=C(CSC1=NN=C(CSCC2=CC=C(C)C=C2)N1C)NC3=CC=C(C=C3Br)Br
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)